Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04477889 · ClinicalTrials.gov registry record
Methodist Health System COVID-19 Patient Registry
A clinical trial of COVID-19, sponsored by Methodist Health System.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT04477889 is a study of COVID-19 that is actively recruiting participants, run by Methodist Health System. The registered enrollment target is 500 participants, below the 55,212-participant average among 203 other COVID-19 trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04477889, a study of COVID-19, is actively recruiting participants, sponsored by Methodist Health System.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective cohort observational registry study that will include data on all patients who are treated at MHS facilities for COVID-19.
Conditions Studied
Interventions
- OTHER Treatment for COVID-19
Study Locations (1)
Texas
- Clinical Research Institute Methodist Health System - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2020-06-20 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04477889
The ClinicalTrials.gov registry entry for NCT04477889 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55,212-participant average among 203 other COVID-19 trials with a reported enrollment target (99% lower). The listed sponsor is Methodist Health System, which has 125 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with COVID-19 appearing as the primary indexed condition, and to 1 intervention - of which Treatment for COVID-19 is the first listed.
NCT04477889 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT04477889 about?
NCT04477889 is a clinical study titled "Methodist Health System COVID-19 Patient Registry". This is a prospective cohort observational registry study that will include data on all patients who are treated at MHS facilities for COVID-19.
What is the current status of trial NCT04477889?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2020-06-20. Estimated completion is 2026-12.
What conditions does trial NCT04477889 study?
This clinical trial studies the following conditions: COVID-19.
What interventions are being tested in trial NCT04477889?
The interventions under investigation include: Treatment for COVID-19 (OTHER).
Who is sponsoring clinical trial NCT04477889?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04477889 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Arginine Replacement Therapy in COVID-19
RECRUITING · Phase 2
-
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
RECRUITING · Phase 2
-
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
RECRUITING
-
COVID-19 Health Adjustments in Nutrition, General Wellness, and Exercise
RECRUITING
-
The Impact of COVID-19 on Maternal and Neonatal Outcomes
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.